Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
A Phase 2A Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Nonalcoholic Steatohepatitis (NASH) (2021)
It is not intended for human or veterinary use, and must not be used for diagnostic, therapeutic, or clinical purposes
Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone in the body to help regulate blood sugar and appetite
A roGFP1-iL carrying the mutations S147CL and H148S has been reported to have the least negative midpoint potential (229 5 mV) of a whole series or roGFP1-iX variants (Lohman and Remington, 2008)
US$ 25.49
US$ 28.02
US$ 22.41
US$ 26.80
US$ 28.68
